Note: This is an archived Handbook entry from 2010.
|Dates & Locations:|| |
This subject has the following teaching availabilities in 2010:Semester 2, Parkville - Taught on campus.
Timetable can be viewed here. For information about these dates, click here.
|Time Commitment:||Contact Hours: 12 x one hour lectures, 6 x two hour Computer Aided Learning practicals, and 12 x two hour seminars during the semester |
Total Time Commitment: Estimated total time commitment of 120 hours
|Prerequisites:|| Both of |
Study Period Commencement:
|Corequisites:|| Both of |
Study Period Commencement:
|Recommended Background Knowledge:||None|
|Non Allowed Subjects:||None|
|Core Participation Requirements:||It is University policy to take all reasonable steps to minimise the impact of disability upon academic study and reasonable steps will be made to enhance a student’s participation in the University’s programs. Students who feel their disability may impact upon their active and safe participation in a subject are encouraged to discuss this with the relevant subject coordinator and the Disability Liaison Unit.|
CoordinatorDr Alex Gentle
The subject will consist of three components: Firstly, a lecture series to guide the student on the formulations available, the indications and contra-indications for their use and the current clinical protocols employed in the use of these formulations. Lecture topics covered will include anti-microbial, anti-viral, anti-inflammatory and anti-glaucoma medications; Secondly, a series of CAL practical sessions in which the student will be encouraged to apply knowledge gained in the lectures to a theoretical series of clinical situations; Thirdly, a series of seminars on the therapeutic management of ocular disease in which the students will prepare and present their management strategies in response to a variety of case histories and the supervising clinician will discuss current best-practice management associated with these cases and highlight issues associated with incorrect diagnosis. By the end of this subject the student will be required to have demonstrated a sound theoretical knowledge of the range and application of specific groups of therapeutic drugs in the management of eye disease.
|Objectives:||The purpose of this subject is to provide students with a sound knowledge of the range of prescription drugs used in the management of eye disease, along with the appropriate protocols and precautions necessary for their safe and effective clinical use.|
A 10-minute oral presentation on a case report during the semester (20%); computer-aided learning assignments due during the semester (20%); a 2-hour written examination in the examination period (60%). An attendance rate of at least 80% is a hurdle requirement for each student for the Ophthalmology Seminar Series.
|Breadth Options:|| |
This subject is not available as a breadth subject.
|Fees Information:||Subject EFTSL, Level, Discipline & Census Date|
This subject is only available to Bachelor of Optometry students.
Bachelor of Optometry |
Download PDF version.